Rhaeos is a clinical stage company developing FlowSense, a platform technology and a noninvasive wireless, wearable skin sensor that can assess fluid flow peripherally throughout the body in and outside of the hospital. The company is initially targeting hydrocephalus, a condition caused by an abnormal accumulation of cerebrospinal fluid (CSF).